je.st
news
UPDATE 1-U.S. FDA approves NPS drug, in move validating Shire takeover deal
2015-01-24 06:29:54| Biotech - Topix.net
The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc's drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed to acquire NPS for $5.2 billion. Natpara is designed to treat hypoparathyroidism, a condition in which the body's parathyroid gland does not secrete enough parathyroid hormone .
Tags: update
move
deal
drug
Category:Biotechnology and Pharmaceuticals